Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PGJ2 | cPLA2i | 1.0 | BCD110605C16 | 0.173 | pmol/ml of medium |
| - | PGJ2 | cPLA2i | 1.0 | BCD110605C18 | 0.126 | pmol/ml of medium |
| - | PGJ2 | cPLA2i | 1.0 | BCD110605C17 | 0.327 | pmol/ml of medium |
| - | PGJ2 | cPLA2i | 4.0 | BCD110605C34 | 0.163 | pmol/ml of medium |
| - | PGJ2 | cPLA2i | 4.0 | BCD110605C36 | 0.396 | pmol/ml of medium |
| - | PGJ2 | cPLA2i | 4.0 | BCD110605C35 | 0.254 | pmol/ml of medium |
| - | PGJ2 | cPLA2i | 20.0 | BCD110605C53 | 0.42 | pmol/ml of medium |
| - | PGJ2 | cPLA2i | 20.0 | BCD110605C54 | 0.513 | pmol/ml of medium |
| - | PGJ2 | cPLA2i | 20.0 | BCD110605C52 | 0.497 | pmol/ml of medium |
| - | PGJ2 | PLDi | 1.0 | BCD110605C10 | 0.147 | pmol/ml of medium |
| - | PGJ2 | PLDi | 1.0 | BCD110605C12 | 0.135 | pmol/ml of medium |
| - | PGJ2 | PLDi | 1.0 | BCD110605C11 | 0.183 | pmol/ml of medium |
| - | PGJ2 | PLDi | 4.0 | BCD110605C30 | 0.305 | pmol/ml of medium |
| - | PGJ2 | PLDi | 4.0 | BCD110605C29 | 0.278 | pmol/ml of medium |
| - | PGJ2 | PLDi | 4.0 | BCD110605C28 | 0.325 | pmol/ml of medium |
| - | PGJ2 | PLDi | 20.0 | BCD110605C48 | 0.364 | pmol/ml of medium |
| - | PGJ2 | PLDi | 20.0 | BCD110605C47 | 0.488 | pmol/ml of medium |
| - | PGJ2 | PLDi | 20.0 | BCD110605C46 | 0.467 | pmol/ml of medium |
| - | PGJ2 | KDO+cPLA2i | 1.0 | BCD110605C19 | 0.397 | pmol/ml of medium |
| - | PGJ2 | KDO+cPLA2i | 1.0 | BCD110605C21 | 0.495 | pmol/ml of medium |
| - | PGJ2 | KDO+cPLA2i | 1.0 | BCD110605C20 | 0.379 | pmol/ml of medium |
| - | PGJ2 | KDO+cPLA2i | 4.0 | BCD110605C39 | 1.07 | pmol/ml of medium |
| - | PGJ2 | KDO+cPLA2i | 4.0 | BCD110605C37 | 0.761 | pmol/ml of medium |
| - | PGJ2 | KDO+cPLA2i | 4.0 | BCD110605C38 | 0.562 | pmol/ml of medium |
| - | PGJ2 | KDO+cPLA2i | 20.0 | BCD110605C55 | 4.61 | pmol/ml of medium |
| - | PGJ2 | KDO+cPLA2i | 20.0 | BCD110605C57 | 4.57 | pmol/ml of medium |
| - | PGJ2 | KDO+cPLA2i | 20.0 | BCD110605C56 | 4.34 | pmol/ml of medium |
| - | PGJ2 | KDO+PLDi | 1.0 | BCD110605C15 | 0.619 | pmol/ml of medium |
| - | PGJ2 | KDO+PLDi | 1.0 | BCD110605C14 | 0.314 | pmol/ml of medium |
| - | PGJ2 | KDO+PLDi | 1.0 | BCD110605C13 | 0.44 | pmol/ml of medium |
| - | PGJ2 | KDO+PLDi | 4.0 | BCD110605C32 | 1.21 | pmol/ml of medium |
| - | PGJ2 | KDO+PLDi | 4.0 | BCD110605C31 | 1.46 | pmol/ml of medium |
| - | PGJ2 | KDO+PLDi | 4.0 | BCD110605C33 | 1.37 | pmol/ml of medium |
| - | PGJ2 | KDO+PLDi | 20.0 | BCD110605C49 | 8.11 | pmol/ml of medium |
| - | PGJ2 | KDO+PLDi | 20.0 | BCD110605C51 | 8.45 | pmol/ml of medium |
| - | PGJ2 | KDO+PLDi | 20.0 | BCD110605C50 | 7.57 | pmol/ml of medium |
| - | PGJ2 | KDO + ATP | 1.0 | BCD110605C07 | 0.44 | pmol/ml of medium |
| - | PGJ2 | KDO + ATP | 1.0 | BCD110605C09 | 0.452 | pmol/ml of medium |
| - | PGJ2 | KDO + ATP | 1.0 | BCD110605C08 | 0.402 | pmol/ml of medium |
| - | PGJ2 | KDO + ATP | 4.0 | BCD110605C25 | 1.55 | pmol/ml of medium |
| - | PGJ2 | KDO + ATP | 4.0 | BCD110605C26 | 1.28 | pmol/ml of medium |
| - | PGJ2 | KDO + ATP | 4.0 | BCD110605C27 | 2.2 | pmol/ml of medium |
| - | PGJ2 | KDO + ATP | 20.0 | BCD110605C45 | 9.07 | pmol/ml of medium |
| - | PGJ2 | KDO + ATP | 20.0 | BCD110605C43 | 7.28 | pmol/ml of medium |
| - | PGJ2 | KDO + ATP | 20.0 | BCD110605C44 | 6.22 | pmol/ml of medium |
| - | PGJ2 | C | 0.0 | BCD110605C02 | 0.361 | pmol/ml of medium |
| - | PGJ2 | C | 0.0 | BCD110605C01 | 0.323 | pmol/ml of medium |
| - | PGJ2 | C | 0.0 | BCD110605C03 | 0.216 | pmol/ml of medium |
| - | PGJ2 | C | 1.0 | BCD110605C06 | 0.277 | pmol/ml of medium |
| - | PGJ2 | C | 1.0 | BCD110605C05 | 0.25 | pmol/ml of medium |